| Today's Top Story |  |  | | - Pharma, regulators, providers must improve trials, report says
Drugmakers can boost the effectiveness of clinical research by collaborating with health care providers and regulators to redevelop how treatments are purchased and reviewed, according to a report from PharmaFutures. Regulators should be more flexible, the think tank said. The industry must move from a fixed-price system to one based on how drugs work in clinical practice. The report was supported by institutional investors. Reuters (6/19)       - Beckman wins FDA nod for advanced test used in MI diagnosis
The FDA has cleared Beckman Coulter, a unit of Danaher, to market its Access AccuTnI+3 troponin I test. The assay, which will run on the company's Access 2 immunoassay platform, has been shown in a clinical study to deliver precise as well as clinically sensitive and specific measurements to help doctors diagnose myocardial infarction. RTT News (6/19)  | Analyst Paper - ARC Brief: Infrastructure: the Hidden Optimization Opportunity
New technologies allow preventative and predictive maintenance coupled with EAM and analytics to be applied to infrastructure. Those responsible for maintaining facilities, fleets, and linear assets should investigate strategies for improving the effectiveness of the maintenance function. Learn more in the free report. |
 | Company & Financial News | | | | - AstraZeneca to set up $500M headquarters, R&D site in the U.K.
AstraZeneca will establish a new global headquarters and research center at the Cambridge Biomedical Campus in England. The move is in line with the drugmaker's plan to build strategic global R&D centers in the U.S., U.K. and Sweden to boost pipeline productivity and establish the firm as an innovation leader. AstraZeneca will invest about $500 million in the site, which will employ roughly 2,000 highly skilled workers by 2016. Reuters (6/18), PharmaTimes (U.K.) (6/18) - Techne to pay $104M for Bionostics
Techne has agreed to pay $104 million to acquire Bionostics, a maker of products to validate whether in vitro diagnostic tools used in blood gas and blood glucose testing are working properly. Techne expects the deal to expand its diagnostic capabilities in new areas such as coagulation, among other things. The Sun (Lowell, Mass.)/The Associated Press (6/18) | Industry Deals | | | | - Sanofi to work with Curie on ovarian cancer targets
Sanofi and the Curie Institute have agreed to cooperate in the search for new therapeutic targets for ovarian cancer using next-generation sequencing, reverse-phase protein analysis and patient-derived xenografts. The three-year collaboration seeks "to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed," the partners said. GenomeWeb Daily News (free registration) (6/19) - 3 agriculture biotech pioneers share 2013 World Food Prize
Three plant biotechnology pioneers have won this year's World Food Prize. The $250,000 prize will be shared by Monsanto Chief Technology Officer Robert Fraley, Syngenta founder Mary-Dell Chilton and Marc Van Montagu, founder and chairman of the Institute of Plant Biotechnology Outreach at Ghent University in Belgium. "These three scientists are being recognized for their independent, individual breakthrough achievements in founding, developing and applying modern agricultural biotechnology," World Food Prize Foundation President Kenneth Quinn said. Reuters (6/19), ABC News/The Associated Press (6/19)  | Customer Excellence: MedTech Business Model Innovation
L.E.K. Consulting believes there is huge opportunity for medical device and medical technology partners to innovate and move away from solely focusing on product innovation and product sales. To be successful, they must evolve towards a new "Customer Excellence" model. Download the free whitepaper. |
 | Industrial & Environmental | | | |  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Save on energy costs through BIO's newest cost-savings program
BIO has recently aligned with APPI Energy, an energy consulting firm, to assist member companies with reducing their energy expenses. APPI Energy, the preferred energy consultant of 140 trade associations and chambers of commerce nationwide, provides solutions to reduce electricity and natural gas costs at no risk or obligation to member companies. Through this program, APPI Energy offers specialized energy cost reduction services, including the identification of reliable and competitive energy suppliers for member companies and the obtaining of competitive bids from the preferred suppliers in deregulated energy markets. Learn more.
| SmartQuote | | | |  | We have all a better guide in ourselves, if we would attend to it, than any other person can be."
--Jane Austen,
British author  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, June 19, 2013
- Tuesday, June 18, 2013
- Monday, June 17, 2013
- Friday, June 14, 2013
- Thursday, June 13, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment